|
|
|
|
| FDU501b | 宫颈癌及癌旁组织组合芯片，附病理分级、TNM和临床分期，50例/50点，替代CR501a | | 点 数 | 50 | 例 数 | 50 | | 行 数 | 5 | 列 数 | 10 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
AT (*) Malignant (I) Malignant (IB) Malignant (II) Malignant (IIIB) Malignant (IIII) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 49 | F | Uterine cervix | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| A2 | 2 | 60 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant | N |
| A3 | 3 | 54 | F | Uterine cervix | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| A4 | 4 | 48 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant | N |
| A5 | 5 | 53 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant | N |
| A6 | 6 | 40 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant | N |
| A7 | 7 | 65 | F | Uterine cervix | Squamous cell carcinoma | * | T1bN0M0 | IB | Malignant | N |
| A8 | 8 | 32 | F | Uterine cervix | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | N |
| A9 | 9 | 48 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| A10 | 10 | 52 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant | N |
| B1 | 11 | 36 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| B2 | 12 | 54 | F | Uterine cervix | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| B3 | 13 | 53 | F | Uterine cervix | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | N |
| B4 | 14 | 50 | F | Uterine cervix | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | N |
| B5 | 15 | 39 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| B6 | 16 | 36 | F | Uterine cervix | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| B7 | 17 | 69 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| B8 | 18 | 27 | F | Uterine cervix | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| B9 | 19 | 68 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| B10 | 20 | 37 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant | N |
| C1 | 21 | 63 | F | Uterine cervix | Squamous cell carcinoma | * | T2N0M0 | II | Malignant | N |
| C2 | 22 | 47 | F | Uterine cervix | Squamous cell carcinoma | 3 | T2N0M0 | II | Malignant | N |
| C3 | 23 | 62 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| C4 | 24 | 46 | F | Uterine cervix | Squamous cell carcinoma | 3 | T2N1M0 | IIIB | Malignant | N |
| C5 | 25 | 49 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| C6 | 26 | 38 | F | Uterine cervix | Squamous cell carcinoma | 3 | T2N0M0 | II | Malignant | N |
| C7 | 27 | 76 | F | Uterine cervix | Squamous cell carcinoma | 3 | T2N0M0 | II | Malignant | N |
| C8 | 28 | 25 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| C9 | 29 | 56 | F | Uterine cervix | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | N |
| C10 | 30 | 43 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant | N |
| D1 | 31 | 48 | F | Uterine cervix | Squamous cell carcinoma | 3 | T2N1M0 | IIIB | Malignant | N |
| D2 | 32 | 27 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1N0M0 | I | Malignant | N |
| D3 | 33 | 40 | F | Uterine cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant | N |
| D4 | 34 | 27 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| D5 | 35 | 39 | F | Uterine cervix | Squamous cell carcinoma | 3 | T4N0M0 | IIII | Malignant | N |
| D6 | 36 | 39 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| D7 | 37 | 48 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| D8 | 38 | 58 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| D9 | 39 | 43 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| D10 | 40 | 37 | F | Uterine cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| E1 | 41 | 42 | F | Uterine cervix | Mucinous adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | N |
| E2 | 42 | 44 | F | Uterine cervix | Adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | N |
| E3 | 43 | 43 | F | Uterine cervix | Adenosquamous carcinoma | * | T2N0M0 | II | Malignant | N |
| E4 | 44 | 64 | F | Uterine cervix | Adenosquamous carcinoma | * | T1bN0M0 | IB | Malignant | N |
| E5 | 45 | 38 | F | Uterine cervix | Adenosquamous carcinoma | * | T1bN0M0 | IB | Malignant | N |
| E6 | 46 | 49 | F | Uterine cervix | Adenosquamous carcinoma | * | T1N0M0 | I | Malignant | N |
| E7 | 47 | 39 | F | Uterine cervix | Cancer adjacent cervical canals tissue with squamous metaplasia | * | * | * | AT | N |
| E8 | 48 | 39 | F | Uterine cervix | Cancer adjacent cervical canals tissue | * | * | * | AT | N |
| E9 | 49 | 37 | F | Uterine cervix | Cancer adjacent cervical canals tissue | * | * | * | AT | N |
| E10 | 50 | 42 | F | Uterine cervix | Cancer adjacent cervical canals tissue | * | * | * | AT | N | | Tissue Marker |
|
|
